Equity · Healthcare
ALKS
Alkermes plc · NasdaqGS
The line runs $37 on 22 May through $49.50 on 18 August, on a scale from $30 to $60. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ALKS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $37 on 22 May 2026 through $49.50 on 18 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
ALKS insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
ALKS reported financials
ALKS reported revenue of $1.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $241.7M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
ALKS earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ALKS institutional holders
12 of the 45 institutional funds we track reported a ALKS position for the quarter ended 30 Jun 2026 — a combined $1.2B; the latest of those filings landed 14 Aug 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
ALKS fails-to-deliver
On 29 Jul 2026, 20 shares of ALKS failed to deliver (about $1K).
Source: SEC fails-to-deliver (CNS) data